Vytorin
Showing 1 - 25 of 39
Metabolic Syndrome Trial in Houston (Simvastatin, Vytorin, Placebo)
Completed
- Metabolic Syndrome
- Simvastatin
- +3 more
-
Houston, TexasBaylor College of Medicine
Jul 21, 2022
Hypercholesterolemia, Hyperlipidemia Trial (Vytorin + Niaspan, Vytorin, Niaspan)
Completed
- Hypercholesterolemia
- Hyperlipidemia
- Vytorin + Niaspan
- +2 more
- (no location specified)
Feb 7, 2022
Vytorin Tablet Among Filipino Patients
Completed
- Hypercholesterolemia
- Vytorin (R) (Ezetimibe + Simvastatin)
- (no location specified)
Feb 7, 2022
Hypercholesterolemia Trial (simvastatin (+) ezetimibe, Comparator: atorvastatin)
Completed
- Hypercholesterolemia
- simvastatin (+) ezetimibe
- Comparator: atorvastatin
- (no location specified)
Feb 7, 2022
Vytorin Reexamination Study (0653A-174)
Completed
- Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
- (no location specified)
Feb 7, 2022
Atherosclerosis, Hypercholesterolemia, Hyperlipoproteinemia Type II Trial (ezetimibe (plus simvastatin), (plus simvastatin))
Completed
- Atherosclerosis
- +2 more
- ezetimibe (plus simvastatin)
- placebo (plus simvastatin)
- (no location specified)
Feb 7, 2022
Cardiovascular Disorder, Diabetes Trial (ezetimibe (+) simvastatin, simvastatin 40 mg or atorvastatin 20 mg, Rosuvastatin)
Completed
- Cardiovascular Disorder
- Diabetes Mellitus
- ezetimibe (+) simvastatin
- +3 more
- (no location specified)
Feb 7, 2022
Type 1 Diabetes, Dyslipidemia Trial in Aurora (Simvastatin, Ezetimibe/Simvastatin)
Completed
- Type 1 Diabetes Mellitus
- Dyslipidemia
-
Aurora, ColoradoBarbara Davis Center for Childhood Diabetes
Oct 19, 2020
Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator : rosuvastatin calcium, Comparator: Placebo (unspecified))
Completed
- Hypercholesterolemia
- ezetimibe (+) simvastatin
- +2 more
- (no location specified)
Feb 7, 2022
Prostate Cancer Trial in Los Angeles (ezetimibe 10mg-simvastatin 40mg)
Completed
- Prostate Cancer
- ezetimibe 10mg-simvastatin 40mg
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jan 28, 2021
Inflammation, Atherosclerosis, Hypercholesterolemia Trial in Buffalo (Simvastatin 40mg, Ezetimibe 10mg)
Active, not recruiting
- Inflammation
- +2 more
- Simvastatin 40mg
- Ezetimibe 10mg
-
Buffalo, New YorkDiabetes and Endocrinology Research Center of WNY
Nov 16, 2020
Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity Trial in Korea, Republic of (Rosuzet 10/5
Recruiting
- Myocardial Infarction
- +2 more
- Ezetimibe 10mg + Rosuvastatin 5mg
- Rosuvastatin 20mg
-
Bucheon, Gyeonggido, Korea, Republic of
- +6 more
Sep 2, 2022
Hypercholesterolemia, Dyslipidemia Trial in Brazil (Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10
Completed
- Hypercholesterolemia
- Dyslipidemia
- Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation.
- Simvastatin 20 mg + Ezetimibe 10 mg and Simvastatin 40 mg + Ezetimibe 10 mg, according to clinical evaluation.
-
Fortaleza, Ceará, Brazil
- +6 more
Jan 20, 2020
Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias Trial (Guideline directed statin therapy, High intensity statin
Not yet recruiting
- Coronary Artery Calcification
- +2 more
- Guideline directed statin therapy
- High intensity statin plus ezetimibe therapy
- (no location specified)
Apr 25, 2023
Acute Myocardial Infarction, Dyslipidemias Trial in Aswan (Ezetimibe 10mg)
Recruiting
- Acute Myocardial Infarction
- Dyslipidemias
- Ezetimibe 10mg
-
Aswan, EgyptAswan Heart Centre
Jul 27, 2021
Atherosclerosis, Cardiovascular Disease Trial in Baltimore (any statin, niacin, Placebo)
Completed
- Atherosclerosis
- Cardiovascular Disease
- any statin
- +2 more
-
Baltimore, MarylandJohns Hopkins Unversity School of Medicine
Oct 4, 2017
Peripheral Artery Disease Trial in Charlottesville (Simvastatin, Ezetimibe, Simvastatin/Ezetimibe)
Completed
- Peripheral Artery Disease
- Simvastatin
- +2 more
-
Charlottesville, VirginiaUniversity of Virgina Health System
Jul 20, 2017
Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)
Inflammation Plaque, Atherosclerotic, Coronary Disease, Renin-Angiotensin System Trial in Seoul (6-month treatment)
Completed
- Inflammation Plaque, Atherosclerotic
- +2 more
- 6-month treatment
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2018
Acute Kidney Injury Trial in Kalamazoo (CXA-10, pravastatin, Vytorin® (combination of simvastatin and ezetimibe))
Completed
- Acute Kidney Injury
- CXA-10
- +2 more
-
Kalamazoo, MichiganJasper Clinical Research & Development, Inc.
May 2, 2016
Cardiovascular Diseases Trial (ezetimibe (+) simvastatin, simvastatin, pravastatin)
Completed
- Cardiovascular Diseases
- ezetimibe (+) simvastatin
- +2 more
- (no location specified)
Jun 23, 2015
Alopecia Areata Trial in Miami (vytorin)
Completed
- Alopecia Areata
- vytorin
-
Miami, FloridaUniversity of Miami
Mar 16, 2015
Atherosclerosis Trial in Seoul (Ezetrol (Ezetimibe), Vytorin (Ezetimibe + Simvastatin))
Withdrawn
- Atherosclerosis
- Ezetrol (Ezetimibe)
- Vytorin (Ezetimibe + Simvastatin)
-
Seoul, Korea, Republic ofKorea University Guro
Mar 17, 2015
Hypercholesterolemia Trial in Incheon (, vytorin)
Completed
- Hypercholesterolemia
- placebo
- vytorin
-
Incheon, Korea, Republic ofGil Medical Center
Nov 1, 2014